Indication
Prosthetic Joint Infection
2 clinical trials
2 products
Clinical trial
Multiple Doses Versus Single Dose of Cefazolin to Prevent Periprosthetic Joint Infection After Revision Arthroplasty: a Multicenter Open-label, Randomized Clinical Trial.Status: Active (not recruiting), Estimated PCD: 2023-12-01
Product
CefazolinClinical trial
Topical Vancomycin for Infection Prophylaxis in Total Hip and Knee ArthroplastyStatus: Not yet recruiting, Estimated PCD: 2027-06-30
Product
Vancomycin